DERM
Journey Medical Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$5.17
+4.13%Forward multiples
Based on analyst estimates
- P/E forward
- 15.43x
- P/E 2026E
- —
- P/E 2027E
- 7.63x
- P/E 2028E
- 3.10x
- P/S forward
- 1.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.54x
- Price / sales
- 2.14x
- Price / cash flow
- -19.48x
Enterprise value
- Enterprise value
- $145.8M
- EV / sales
- 2.14x
- EV / EBITDA
- 77.94x
- EV / EBIT
- -48.48x
- Market cap
- $145.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026